• Home /
  • News /
  • News archive /
  • German-British consortium investigates reliability and relevance of NAMs on behalf of ECHA
Rate this item
(0 votes)
Friday, 02 February 2024 11:15

German-British consortium investigates reliability and relevance of NAMs on behalf of ECHA Featured

The European Chemicals Agency (ECHA) has commissioned a consortium with the participation of BASF SE to scientifically investigate the reliability and relevance of new technologies as alternatives to animal testing, so-called New Approach Methodologies (NAMs), and to promote their use in the future. NAMs include in-vitro models, computer methods and omics techniques (genetic analyses of the entire genome, all expressed proteins of a cell and metabolic functions).

The contract research project is led by the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) (Hannover). Partners are BASF's Department of Experimental Toxicology and Ecology, the University of Birmingham (England) and the biotechnology companies BioClavis in Glasgow (Scotland) as well as Novogene Europe, Cambridge (England). The project is coordinated by Michabo Health Science, Coventry (England), together with BASF Metabolome Solutions (Berlin).

Source and further information:
https://www.basf.com/global/de/media/news-releases/2024/02/p-24-116.html

https://www.item.fraunhofer.de/

 

More in this category: « Organ-on-chip researcher appointed to DFG committee 3R funding in Austria: call for proposals enters the next round »
back to top